Share:
Peer-Reviewed Publication
Inorg Chem2026;65(32):18925-18937.August 17, 2026Journal Article

Refinement of the Magnetic Behavior of Nanostructured Ni-Fe-OH Layered Double Hydroxides.

Mariia Holub1,2, Elena L Fertman3, Alexey V Fedorchenko3, Yurii G Pashkevich4, Antoine Barbier5, Razvan Burcea6,7, Brahim Dkhil6, Frédéric Fossard7, Philippe Ohresser2, Cristina S Neves8, Andrei N Salak8, Erik Čižmár9
1Faculty of Physics and Applied Computer Science, AGH University of Krakow, al. A. Mickiewicza 30, 30-059Krakow, Poland.
2Synchrotron SOLEIL, L'Orme des Merisiers, 91192Gif sur Yvette Cedex, France.
3B. Verkin Institute for Low Temperature Physics and Engineering of NASU , 61103Kharkiv, Ukraine.
4O. Galkin Donetsk Institute for Physics and Engineering of NASU, 03028Kyiv, Ukraine.
5SPEC, CEA-Saclay, CNRS, Université Paris-Saclay, 91191Gif-sur-Yvette Cedex, France.
6CentraleSupelec, Université Paris-Saclay, 91191Gif-sur-Yvette Cedex, France.
7Université Paris Saclay, ONERA, CNRS, Laboratoire d'étude des microstructures, 92322Châtillon, France.
8Department of Materials and Ceramics Engineering, CICECO - Aveiro Institute of Materials, University of Aveiro, 3810-193Aveiro, Portugal.
9Institute of Physics, Faculty of Science, P.J. Šafárik University in Košice, 04154Košice, Slovakia.

Abstract

Magnetic properties of OH--intercalated Ni2+-Fe3+ layered double hydroxides (LDH) with a nickel-to-iron ratio (n) of 2 and 3, prepared using two independent synthesis methods, have been studied using the macroscopic magnetic method (SQUID magnetometry) and local-scale element-specific techniques (synchrotron-radiation-based soft X-ray XAS and XMCD). It was revealed that synthesis of NinFe-OH LDH u…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.